Djuzenova, C. S., Fiedler, V., Katzer, A., Michel, K., Deckert, S., Zimmermann, H., . . . Flentje, M. (2016). Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule. Oncotarget.
Chicago Style CitationDjuzenova, Cholpon S., Vanessa Fiedler, Astrid Katzer, Konstanze Michel, Stefanie Deckert, Heiko Zimmermann, Vladimir L. Sukhorukov, i Michael Flentje. "Dual PI3K- and MTOR-inhibitor PI-103 Can Either Enhance or Reduce the Radiosensitizing Effect of the Hsp90 Inhibitor NVP-AUY922 in Tumor Cells: The Role of Drug-irradiation Schedule." Oncotarget 2016.
Cita MLADjuzenova, Cholpon S., et al. "Dual PI3K- and MTOR-inhibitor PI-103 Can Either Enhance or Reduce the Radiosensitizing Effect of the Hsp90 Inhibitor NVP-AUY922 in Tumor Cells: The Role of Drug-irradiation Schedule." Oncotarget 2016.